This program includes knowledge and technology transfer, capacity building projects and the fostering of innovative and integrated care models, are designed towards the vision of establishing genomic medicine in Bahrain and improving public health.

Advances in genomics, clinical diagnostic methods and therapies are now fueling healthcare. By integrating clinical data and genetic information, healthcare providers can improve population screening, diagnosis, prognosis, risk management, and in some cases, offer new and innovative targeted therapy for conditions such as cardiovascular diseases, lipid disorders, diabetes, cancer, among many other clinically complex morbidities.

In the Middle East, genetic disorders represent a large proportion of healthcare expenditures and corresponding societal impact. These disorders are the most challenging to address due to enormous phenotypic and genetic heterogeneity. Genetic diseases are significantly more prevalent in the Arab countries, and also comprise one of the leading causes of infant mortality in this part of the world.

There are approximately 7,000 clinically described genetic diseases, and only about half of these have a clearly described genetic cause. Characterizing novel genetic phenotypes and identifying the genes responsible can yield critical new insights into human biology, empowering the development of novel or tailored therapies for these diseases as well as for more common conditions, contributing to precision medicine

Partner Institutions